Click to Share
 

Drug Development Press Releases

Exclusive News
Topics Locations Industries Dates

By Neurolixis, Inc.
Neurolixis issued a new US patent for treatment of Fragile X syndrome with NLX-101
12973824
By Wei Wang, PhD
IVIEW Therapeutics Inc. a clinical stage biotechnology company focusing on developing innovative ophthalmic therapeutics, organized a panel of dry eye experts and clinicians to gain key insights on dry eye treatment innovations.

Page updated every 10 minutes
Trending
Most Viewed
Daily News


Like PRLog?
9K2K1K
Click to Share